KC
CORT icon

Kepos Capital’s Corcept Therapeutics CORT Stock Holding History

Kepos Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-68,368
Closed -$762K – 328
2019
Q2 		$762K Hold
68,368
– – 0.08% 182
2019
Q1 		$803K Hold
68,368
– – 0.06% 227
2018
Q4 		$913K Hold
68,368
– – 0.07% 217
2018
Q3 		$959K Sell
68,368
-11,569
-14% -$162K 0.05% 228
2018
Q2 		$1.26M Hold
79,937
– – 0.06% 206
2018
Q1 		$1.31M Buy
+79,937
New +$1.48M 0.08% 159

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kepos Capital's CORT Position: Q3 2019 in Review

Kepos Capital sold out of Corcept Therapeutics (CORT) in Q3 2019, closing a stake of 68,368 shares — an estimated $762K sold.

Kepos Capital first reported a position in CORT in Q1 2018 and held it in 6 quarters. The position peaked at $1.31M in Q1 2018. 193 funds tracked by Wall St. Rank hold CORT as of Q3 2019.

  • Kepos Capital reported no remaining Corcept Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Kepos Capital sold 68,368 Corcept Therapeutics shares in Q3 2019, an estimated $762K.
  • Kepos Capital first reported a position in Corcept Therapeutics in Q1 2018 and held it in 6 quarters.
  • Kepos Capital's Corcept Therapeutics position peaked at $1.31M in Q1 2018.
  • 193 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2019.

Based on Kepos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.